Logest 21 tablets — Made in Germany by Bayer — Free Delivery

Product description 

Compound

Contraindications

• venous thromboembolic events at present (anticoagulant therapy) or in history (for example, deep vein thrombosis (DVT) or pulmonary embolism (PE));
• known hereditary or acquired tendency to thrombosis, venous thromboembolism (eg resistance to activated protein C, including factor V Leiden), antithrombin III deficiency, protein C deficiency, protein S deficiency;
• major surgical interventions with prolonged immobilization;
• high risk of venous thromboembolism due to the presence of multiple risk factors.

• arterial thromboembolism - the presence of arterial thromboembolism at present or in history (for example, myocardial infarction (MI)) or the presence of prodromal conditions (for example, angina pectoris);
• cerebrovascular disease - the presence of a stroke at present or in history, or the presence of prodromal conditions (for example, transient ischemic attack (TIA));
• known hereditary or acquired tendency to arterial thromboembolism (eg hyperhomocysteinemia) or the presence of antiphospholipid antibodies (anticardiolipin antibodies, lupus anticoagulant);
• migraine with a history of focal neurological symptoms;
• high risk of arterial thromboembolism due to the presence of multiple risk factors or the presence of one of the serious risk factors, such as diabetes mellitus with vascular damage, severe arterial hypertension, severe dyslipoproteinemia;
• current or history of severe liver disease until liver function tests return to normal;
• the presence or history of liver tumors (benign or malignant);
• known or suspected hormone-dependent malignant tumors (for example, genital or mammary glands);
• vaginal bleeding of unknown etiology;
• hypersensitivity to the active substances or to any of the components of the preparation.

Mode of application

Application features

Overdose

Side effects

Storage conditions